NS

Narayana Swamy Jagadeesh

Active Director Additional Director DIN 11014230
DIN 11014230 First appointment Mar 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Narayana Swamy Jagadeesh

Data last updated:

Narayana Swamy Jagadeesh is an Additional Director at Medidrogue Pharmaceuticals Private Limited (since 2025). The company operates in Paper.

DIN 11014230
Primary Designation Additional Director
Industry Paper
First Appointment 24 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director24 Mar 20252025Active

Directorship timeline

Open interactive timeline →
Medidrogue Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Narayana Swamy Jagadeesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narayana Swamy Jagadeesh

Narayana Swamy Jagadeesh currently holds 1 directorship: Medidrogue Pharmaceuticals Private Limited (Additional Director, since 24 Mar 2025).

Narayana Swamy Jagadeesh was first appointed on 24 Mar 2025 as Additional Director at Medidrogue Pharmaceuticals Private Limited.

The current boards of Narayana Swamy Jagadeesh's companies include Byrareddy Cheemalagutta Manjunath (Medidrogue Pharmaceuticals Private Limited), Murali Gurappa Ramachandrappa (Medidrogue Pharmaceuticals Private Limited), Narayana Swamy Chowda Reddy (Medidrogue Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available